The FDA has accepted the NDA for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.

The numbers are as alarming as they are tragic. From 2021 to 2023, there were 3,228 visits to emergency departments in Ottawa hospitals for opioid overdoses and 512 deaths. In 2023 alone ...

A recent systematic review published in the Journal of American Medical Association revealed that stricter opioid prescribing ...

The firm highlighted the biopharmaceutical company's diversified business model, which includes its over-the-counter (OTC) opioid overdose reversal product NARCAN, its infectious disease vaccines ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

With Gov. Maura Healey’s signature last week, the state mandated that insurance providers cover overdose reversal drugs such as naloxone, commonly known by the brand name Narcan. Passed by the ...

Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

The number of incidents where paramedics make use of Narcan for overdose-related emergencies has gone down in 2024. Davies attributes the decline to the efforts of many community stakeholders but ...

Dec. 22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia. Both forms of treatment produced a ...

Scilex Holding Company ( (SCLX) ) has provided an update.